Bacteria and enzymes in treatment systems

The biological basis of treatment

Biological systems harness naturally occurring processes: microbial communities use organic compounds as sources of carbon and energy, transforming them into biomass, carbon dioxide, water and other products according to operating conditions. Treatment plants organise these processes within controlled reactors to reduce pollutant loads before discharge or reuse.

A biological solution is not simply a matter of adding microorganisms. Performance depends upon temperature, pH, oxygen, nutrients, retention time, toxicity and hydraulic balance. Understanding these variables is essential when evaluating an intervention and prevents expectations from becoming detached from the evidence available for the system.

What beneficial bacteria are

Beneficial bacteria are microorganisms selected for metabolic capabilities relevant to an application, such as breaking down fats, proteins, carbohydrates or particular compounds. In treatment environments they may complement existing communities, support recovery after disturbance or help manage specific loads. Their behaviour is always conditioned by the ecosystem into which they are introduced.

Microbial diversity can add resilience because different organisms act upon different substrates and tolerate different conditions. Compatibility, safety, formulation, storage and application method nevertheless require careful review. Identifying a bacterial species is not sufficient to predict the behaviour of a complex installation.

What industrial enzymes are

Enzymes are proteins that accelerate chemical reactions. Proteases, lipases, amylases and cellulases act upon proteins, fats, starches and cellulose respectively, dividing large molecules into more accessible fractions. This hydrolysis may help microbial communities continue the degradation process.

Activity depends upon pH range, temperature, contact time, inhibitors and substrate concentration. An enzyme that performs well in a laboratory may behave differently in a drain network or reactor. Professional assessment therefore considers the real matrix, dosage, stability and interaction with chemicals already present.

Organic matter, odour and process balance

Accumulated organic matter may raise oxygen demand, create deposits and encourage anaerobic conditions. Odours arise when volatile compounds such as sulphides, amines or organic acids are formed and released. Biological strategies seek to address the cause —substrate and operating conditions— rather than merely masking the smell.

A sound strategy may combine improved aeration, solids removal, hydraulic control, targeted dosing and analytical monitoring. If toxic discharge, nutrient deficiency or inadequate retention time is the underlying problem, adding biology alone will not correct it. Diagnosis comes before methodology selection.

Wastewater and industrial applications

Bacteria and enzymes may be considered for biological reactors, lagoons, conveyance systems, grease traps and decentralised treatment. Industrial applications may involve streams containing fats and oils, food residues, biodegradable organic matter or seasonal load variation. Each case requires characterisation and compatibility with the existing process.

Monitoring may include chemical and biochemical oxygen demand, solids, fats, dissolved oxygen, pH, redox potential, sludge production and odour behaviour. Results should be read as trends and related to flow, production and operational changes so that a genuine improvement is distinguished from normal variation.

Environmental benefits and the circular economy

Properly designed biological processes may treat organic matter efficiently and reduce dependence upon intensive treatment methods. They may also support waste stabilisation, water recovery or the valorisation of organic streams. Environmental benefit should be assessed across the whole system, including energy, auxiliary products, sludge, transport and final destination.

The circular economy seeks to retain resources in productive use. Biotechnology may contribute to biogas generation, nutrient recovery and valuable bioproducts. Not every stream is suitable, and safety, quality and commercial feasibility remain essential conditions.

Good practice, trials and responsible interpretation

Assessment begins with a baseline covering water composition, variability, plant design, operating history and a measurable objective. A trial then defines controls, duration, responsibilities and success criteria. Dosage should follow technical and safety documentation rather than being extrapolated directly from another installation.

Trials should answer a specific question and record production, temperature, rainfall, discharges and shutdowns alongside the selected indicators. Changing aeration, chemicals, flow and operation simultaneously makes attribution unreliable. At completion, performance, consumption, cost, safety, residues and the operator's ability to maintain the method should all be considered.

• Characterise the stream and establish a baseline.
• Define objectives, indicators and assessment period.
• Control operational variables throughout the trial.
• Review safety, regulation and ongoing management.

Innovation and AquaVance's role

Innovation is advancing through better-characterised microbial consortia, more stable enzymes, immobilisation, carrier materials, molecular analysis and digital control. Metagenomics provides insight into communities without relying solely upon culture, whilst sensors and modelling may support faster decisions. These tools expand understanding but do not remove the need to interpret the complete process.

AquaVance seeks to bring advanced British biological knowledge and technologies closer to Latin America through professional partnerships and responsible assessment. We can help organisations structure initial information, identify the questions that require clarification and explore capabilities that are coherent with a genuine application.